Riskpilot← Back to searchSign inGet full accessAG medical AB
ABActiveOrg 5592823685Södra Allégatan 12General medical practice activities · NACE 8621Est. 20201-4 employees
Revenue 2024
SEK 2,4M
+94% vs 2023
EBITDA margin
14.3%
+427% vs 2023
Equity ratio
32.4%
Financial strength
Net profit 2024
SEK 307K
+346% vs 2023
| Revenue | SEK 2,4M | +94% |
| EBITDA | SEK 340K | +427% |
| Net profit | SEK 307K | +346% |
| Total assets | SEK 3M | +18% |
| Equity | SEK 978K | +46% |
| Employees | — | — |
Legal name
AG medical AB
Org number
5592823685
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 november 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Aljaderi, Maythem Jawdah
Company purpose
Intygsförskrivning, såsom högre behörighet för körkort och sjöfartsintyg.
Address
Södra Allégatan 12
Email
info@intygslakaren.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 3 279 | 2 026 | 1 229 | 2 380 |
| Staff expenses | −76 | −477 | — | — |
| EBITDA | 1 557 | 307 | −104 | 340 |
| Depreciation & amort. | — | −58 | −70 | −70 |
| EBIT | 1 557 | 249 | −174 | 270 |
| Net financials | −0 | −5 | −23 | −85 |
| Profit before tax | 1 556 | 172 | −125 | 385 |
| Tax | −340 | −45 | −0 | −78 |
| Net profit | 1 216 | 127 | −125 | 307 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2 143 | 1 942 | 2 560 | 3 015 |
| Equity | 1 241 | 1 368 | 671 | 978 |
| Long-term debt | 19 | 0 | 1 112 | 846 |
| Short-term debt | 883 | 502 | 777 | 1 190 |
| Total debt | 902 | 502 | 1 889 | 2 036 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212024
Equity ratio
32.4%
This company
38.2%
Market median
+15% vs market
20212024
Return on equity
31.4%
This company
18.4%
Market median
+71% vs market
20212024
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20212024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20212024
Debt / equity
2.08×
This company
0.62×
Market median
-235% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-11 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
KJ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AG medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kumayl Jawdah Aljaderi | Chief Executive Officer | 0 companies |
| Maythem Jawdah Aljaderi | Chief Executive Officer | 0 companies |
| Huda Abed Aljaderi | Deputy Board Member | 0 companies |
| Mohammad Mohammad Aljaderi | Deputy Board Member | 0 companies |